CO2017001076A2 - Composiciones farmacéuticas antihiperalgésicas, antialodínicas y antiinflamatorias que contienen pregabalina y meloxicam - Google Patents

Composiciones farmacéuticas antihiperalgésicas, antialodínicas y antiinflamatorias que contienen pregabalina y meloxicam

Info

Publication number
CO2017001076A2
CO2017001076A2 CONC2017/0001076A CO2017001076A CO2017001076A2 CO 2017001076 A2 CO2017001076 A2 CO 2017001076A2 CO 2017001076 A CO2017001076 A CO 2017001076A CO 2017001076 A2 CO2017001076 A2 CO 2017001076A2
Authority
CO
Colombia
Prior art keywords
antihyperalgesic
pharmaceutical compositions
meloxicam
allodinic
compositions containing
Prior art date
Application number
CONC2017/0001076A
Other languages
English (en)
Inventor
Armenta Maria Elena Garcia
Ochoa Victor Guillermo Alvarez
Original Assignee
Pptm Int S A R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53938368&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO2017001076(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pptm Int S A R L filed Critical Pptm Int S A R L
Publication of CO2017001076A2 publication Critical patent/CO2017001076A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una novedosa combinación farmacéutica sinérgica de un agente antihiperalgésico, antialodínico y un agente antiinflamatorio, en donde el agente antihiperalgésico, antialodínico es Pregabalina, y el agente antiinflamatorio es Meloxicam. La presente invención además está dirigida a composiciones farmacéuticas que comprenden dicha combinación, y al uso de dicha combinación y composiciones farmacéuticas para la prevención y/o tratamiento del dolor neuropático ocasionado por diversas etiologías.
CONC2017/0001076A 2014-07-07 2017-02-06 Composiciones farmacéuticas antihiperalgésicas, antialodínicas y antiinflamatorias que contienen pregabalina y meloxicam CO2017001076A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2014008336A MX2014008336A (es) 2014-07-07 2014-07-07 Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico.
PCT/IB2015/055127 WO2016005897A1 (en) 2014-07-07 2015-07-07 Combination of pregabalin and meloxicam for the treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
CO2017001076A2 true CO2017001076A2 (es) 2017-05-31

Family

ID=53938368

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0001076A CO2017001076A2 (es) 2014-07-07 2017-02-06 Composiciones farmacéuticas antihiperalgésicas, antialodínicas y antiinflamatorias que contienen pregabalina y meloxicam

Country Status (5)

Country Link
BR (1) BR112017000359A2 (es)
CO (1) CO2017001076A2 (es)
MX (1) MX2014008336A (es)
PE (1) PE20171140A1 (es)
WO (1) WO2016005897A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11590094B2 (en) 2017-09-28 2023-02-28 Nevakar Injectables Inc. Fixed dose combination formulations for treating pain
MX2019008467A (es) * 2019-07-16 2019-11-07 Federico Amezcua Amezcua Combinacion sinergica de s-ketorolaco y pregabalina en una composicion farmaceutica para el tratamiento del dolor neuropatico.
CN112353767A (zh) * 2020-11-16 2021-02-12 海南锦瑞制药有限公司 一种盐酸地尔硫卓和普瑞巴林组合物及其制备方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129907A (en) 1999-08-04 2000-10-10 Colgate Palmolive Company Stable hydrogenated lupulone antibacterial oral compositions
WO2003066040A1 (fr) 2002-02-05 2003-08-14 Ajinomoto Co.,Inc. Compositions medicinales contenant une gabapentine ou une pregabaline et antagoniste a canal de calcium de type n
DE10331305A1 (de) 2003-07-10 2005-02-17 Siemens Ag Kommunikationssystem, Peer-to-Peer-Nachrichten-Filter-Rechner und Verfahren zum Verarbeiten einer Peer-to-Peer-Nachricht
BRPI0610316A2 (pt) 2005-05-20 2010-06-15 Pfizer Ltd combinações sinergìsticas de medicamentos atiinflamatórios não estereoidais com alfa-delta-ligantes
CA2701838A1 (en) 2007-10-09 2009-04-16 Merck Patent Gmbh Pharmaceutical compositions containing benfotiamine and one or more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin
ES2619329T3 (es) 2007-11-23 2017-06-26 Grünenthal GmbH Composiciones de tapentadol
MX336979B (es) 2011-12-16 2016-02-09 Senosiain S A De C V Lab Combinacion farmaceutica antineuritica y composiciones.

Also Published As

Publication number Publication date
WO2016005897A1 (en) 2016-01-14
BR112017000359A2 (pt) 2018-06-26
PE20171140A1 (es) 2017-08-09
MX2014008336A (es) 2016-01-07

Similar Documents

Publication Publication Date Title
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CL2020002032A1 (es) Cristal de un compuesto derivado de 7,8-difluoro-6,11-dihidrodibenzotiepina, composición farmacéutica, útil en reducir el tiempo de alivio de los síntomas de la influenza para tratar y/o prevenir una infección provocada por el virus de la influenza. (divisional solicitud 201900325).
CL2018003588A1 (es) Uso de inhibidores de miostatina y terapias de combinación.
SV2018005778A (es) Derivados aromaticos de sulfonamida
BR112018004620A2 (pt) moduladores da expressão de kras
CL2018001996A1 (es) Composiciones y métodos para modular la expresión del factor b del complemento (divisional de solicitud 2764-16)
BR112017022089A2 (pt) uso de uma composição, e, método para branqueamento de dentes
CR20160433A (es) Nuevos compuestos
NI202100018A (es) Moduladores de la expresión de pnpla3
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
CL2019001996A1 (es) Usos terapéuticos de un polvo de insectos.
GT201500247A (es) Imidazopiridazinas sustituidas
CL2017002214A1 (es) Formulación de combinación de tesofensina y betabloqueante
CR20190471A (es) Moduladores de la expresión de pcsk9
BR112016013754A2 (pt) Recaptação de serotonina-norepinefrina inibidores (irsns) e combinações dos ligantes do receptor sigma
CL2019001746A1 (es) Amidas aromáticas de ácido carboxílico
CO2017001076A2 (es) Composiciones farmacéuticas antihiperalgésicas, antialodínicas y antiinflamatorias que contienen pregabalina y meloxicam
CL2019001618A1 (es) Uso de compuestos de carbamato para prevención, alivio o tratamiento del trastorno bipolar.
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
CO2020003134A2 (es) Moduladores de la expresión de enac
AR106415A1 (es) Composición farmacéutica para el tratamiento del dolor
CU20170134A7 (es) 2-tiopirimidinonas
CO2019007261A2 (es) Combinación de un inhibidor de mcl-1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta
BR112019006591A2 (pt) derivado de oxazina para uso no tratamento ou prevenção de angiopatia amiloide cerebral
AR102215A1 (es) Compuesto de pirazol-4-carboxamida, composición farmacéutica que lo comprende y su uso para la fabricación de un medicamento